Collecting Duct Carcinoma Survival Rate

Histochemical and immunohistochemical studies are often necessary for the diagnosis of collecting duct carcinoma.
Collecting duct carcinoma survival rate. We present the results of a systematic review addressing the management of cdc and the mcmaster university cdc series. 1 these tumours are found to be locally advanced and with distant metastasis at presentation with 1 to 3 years disease specific survival. People with these types of cancer may have a poorer. Symptoms may include flank pain unexplained weight loss or blood in the urine.
The prognosis is poor and most patients develop metastases or die 120 121 136 137 within 2 years of presentation. Little is known concerning the optimal management of cdc. Collecting duct carcinoma cdc is a rare and aggressive form of kidney cancer that begins in the collecting duct of the kidney. Many people with cdc have no signs or symptoms until the cancer is at an advanced stage.
Collecting duct carcinomas are rare aggressive malignancies with poor prognosis arising from collecting duct epithelium of the kidney accounting for about 1 3 of all renal cell carcinoma rcc.